PECAM1 and neoplasm: Using this cutoff of 4% for the population of CD31+ integrin β1+ Sca1- cells, shows that a low percentage is associated with more tumor cells in the bone marrow, except in Lepr-β1 (Fig. 4c, f, i, l).